(You can say you never saw it here or this is where you found it)
The Cannabis industry is growing here in Arizona, here in the United States and world-wide and up there in Canada. It means investments in real estate and job creation.
Within a few years, more states have approved both recreational and medicinal use, as well as extracts from carefully-grown and crafted Cannabis species under cultivation for scientific applications in the treatment of PTSD, epilepsy and manic-depressive mood disorders.
This is just one more post in a number where Cannabis is the featured
______________________________________________________________
AgraFlora Organics Makes Strategic Investment and Empower Announces Closing of Debenture and Private Placement Unit Offerings
The Cannabis industry is growing here in Arizona, here in the United States and world-wide and up there in Canada. It means investments in real estate and job creation.
Within a few years, more states have approved both recreational and medicinal use, as well as extracts from carefully-grown and crafted Cannabis species under cultivation for scientific applications in the treatment of PTSD, epilepsy and manic-depressive mood disorders.
This is just one more post in a number where Cannabis is the featured
______________________________________________________________
AgraFlora Organics Makes Strategic Investment and Empower Announces Closing of Debenture and Private Placement Unit Offerings
Empower Clinics Inc.
VANCOUVER, April 2, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE: EPW) (Frankfurt 8EC) ("Empower" or the "Company"), a growth oriented and diversified medical cannabis company, is pleased to announce the closing of its non-brokered private placement of unsecured convertible debentures (the "Debentures") in the aggregate principal amount of $799,500.00 and its non-brokered private placement of an aggregate of 21,115,000 units of the Company (each, a Unit") at a price of $0.10 per Unit for gross proceeds of $2,115,000.00 for a total of $2,914,500.00 (together, the "Offerings").
The proceeds of the Offerings are expected to be used by the Company for the completion of strategic acquisitions and for general working capital and corporate purposes.
"The strong support in our financing round demonstrates that shareholders and investors have faith in our ability to execute on initiatives, as we establish vertical integration, connecting patient efficacy in our clinics with a diverse CBD product strategy and the backing of the science of extraction, all driven by data and analysis." stated Steven McAuley, Empower Chairman and CEO.
Derek Ivany, President and CEO of AgraFlora commented, "As interest in cannabidiol (CBD) continues to expand both amongst the medical community and with retail consumers alike, we are excited to be making this strategic investment into Empower as they embark on this next phase of their growth plan. With the prospect of multiple near term revenue streams and a robust clinic and patient network the Company presents a compelling platform from which to build upon. We have been further assessing corporate synergy with Empower and look forward to collaborating on new initiatives in short order."
RECENT HIGHLIGHTS
> The Debentures are convertible, at the option of the Company or the holder, into units of the Company (each, a "Debenture Unit") at a conversion price of $0.11 per Debenture Unit, with each Debenture Unit consisting of one common share in the capital of the Company (each, a "Share") and one share purchase warrant (each, a "Warrant"), with each Warrant exercisable into one Share (each, a "Warrant Share") at a price of $0.16 per Warrant Share for a period of two years following the Closing, provided that the Company will have the right to accelerate the expiry date of the Warrants in the event that the closing sale price of the Shares on the Canadian Securities Exchange (the "CSE") (or such other stock exchange as the Shares are then principally traded) is greater than $0.40 per Share for a period of 10 consecutive trading days at any time after the issuance of the Warrants.
Each Unit is comprised of one Share and one Warrant, with each Warrant exercisable into one Warrant Share at an exercise price of $0.16 per Warrant Share for a period of two years following the Closing, provided that the Company will have the right to accelerate the expiry date of the Warrants in the event that the closing sale price of the Shares on the CSE (or such other stock exchange as the Shares are then principally traded) is greater than $0.40 per Share for a period of 10 consecutive trading days at any time after the issuance of the Warrants.
> The Debentures and the Units, and the underlying Shares, Warrants and Warrant Shares (collectively, the "Securities"), are subject to restrictions on resale under applicable Canadian securities laws for a period of four months and one day from the closing of the Offerings.
> None of the Securities have been or will be registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.
> This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities, in any jurisdiction in which such offer, solicitation or sale would require registration or otherwise be unlawful.
_________________________________________________________________________________
ABOUT EMPOWER
Empower is a leading owner/operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative uses of medical cannabis. It is expected that Empower's proprietary product line "Sollievo" will offer patients a variety of delivery methods of doctor recommended cannabidiol (CBD) based product options in its clinics, online and at major retailers. With over 120,000 patients, an expanding clinic footprint, a focus on new technologies, including tele-medicine, and an expanded product development strategy, Empower is undertaking new growth initiatives to be positioned as a vertically integrated, diverse, market-leading service provider for complex patient requirements in 2019 and beyond.
ABOUT AGRAFLORA
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry. For more information please visit: www.agraflora.com
_________________________________________________________________________________
SEE > DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
https://www.newswire.ca/news-releases
_________________________________________________________________________________
Related Links
www.adiraenergy.com
Apr 02, 2019, 05:30 ET
AgraFlora Organics International Inc. CSE: AGRA makes a $1,000,000.00 investment to support the Empower growth plan, as Empower closes over $2,900,000.00 in debenture and equity financing.VANCOUVER, April 2, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE: EPW) (Frankfurt 8EC) ("Empower" or the "Company"), a growth oriented and diversified medical cannabis company, is pleased to announce the closing of its non-brokered private placement of unsecured convertible debentures (the "Debentures") in the aggregate principal amount of $799,500.00 and its non-brokered private placement of an aggregate of 21,115,000 units of the Company (each, a Unit") at a price of $0.10 per Unit for gross proceeds of $2,115,000.00 for a total of $2,914,500.00 (together, the "Offerings").
The proceeds of the Offerings are expected to be used by the Company for the completion of strategic acquisitions and for general working capital and corporate purposes.
"The strong support in our financing round demonstrates that shareholders and investors have faith in our ability to execute on initiatives, as we establish vertical integration, connecting patient efficacy in our clinics with a diverse CBD product strategy and the backing of the science of extraction, all driven by data and analysis." stated Steven McAuley, Empower Chairman and CEO.
Derek Ivany, President and CEO of AgraFlora commented, "As interest in cannabidiol (CBD) continues to expand both amongst the medical community and with retail consumers alike, we are excited to be making this strategic investment into Empower as they embark on this next phase of their growth plan. With the prospect of multiple near term revenue streams and a robust clinic and patient network the Company presents a compelling platform from which to build upon. We have been further assessing corporate synergy with Empower and look forward to collaborating on new initiatives in short order."
RECENT HIGHLIGHTS
- Intention to Launch CBD Extraction Facility The Company intends to open a fully functioning hemp-based CBD extraction facility in greater Portland, Oregon in Q2 2019, with the first extraction system expected to have the capacity to produce 6,000 kilograms of extracted product per year. Empower has entered into a non-binding term sheet with Aibeida LifeTech Ltd. ("Aibeida"), whereby Aibeida has agreed to: sell and license specialized extraction equipment to Empower; provide facility build-out and set-up services; complete licensing and permitting requirements; perform equipment set-up, testing and activation; and provide ongoing facility management and maintenance for the first Empower CBD extraction facility. Aibeida's director and Chief Scientist, Dr. Shuang Xie, PhD, will oversee and manage the Empower CBD extraction facility, which is expected to provide Empower with vertical integration into the CBD supply chain, producing isolates, distillates and crude oil that have shown successful third party test results in Aibeida's initial test facility.
- Proposed Acquisition of Sun Valley Clinics Empower has entered into a non-binding term sheet to acquire the business of Sun Valley Certification Clinics Holdings LLC ("Sun Valley"), including its interests in certain affiliates, by way of a share or asset acquisition, subject to due diligence and customary closing conditions. Sun Valley operates a network of professional medical cannabis and pain management practices, with five clinics in Arizona, one clinic in Las Vegas, a tele-medicine platform serving California, and a fully developed franchise business model for the domestic cannabis industry. The current Sun Valley clinic locations are as follows:
4218 W Dunlap Ave, Phoenix, AZ
12801 W Bell Rd #145, Surprise, AZ
4015 E Bell Rd #130, Phoenix, AZ
2011 E University Dr, Mesa, AZ
7074 E Speedway Blvd, Tucson, AZ
2550 S Rainbow Blvd, Las Vegas, NV
12801 W Bell Rd #145, Surprise, AZ
4015 E Bell Rd #130, Phoenix, AZ
2011 E University Dr, Mesa, AZ
7074 E Speedway Blvd, Tucson, AZ
2550 S Rainbow Blvd, Las Vegas, NV
- Focus on CBD Product Sales Empower has commenced selling its proprietary line of CBD-based products called SOLLIEVO, through its network of company-owned clinics in the United States. Empower's patient base and customers are expected to benefit from access to high margin derivative products, including CBD lotion, tinctures, spectrum oils, capsules, lozenges, patches, e-drinks, topical lotions, gel caps, hemp extract drops and pet elixir hemp extract drops. Patients and customers will be able to access Empower's home delivery and e-commerce platform.
- CBD Market Demand The passing in the United States of the US$867 billion Agriculture Improvement Act (the "Farm Bill") has legalized hemp and hemp-based products. This has created an opportunity for the production and sale of a variety of CBD-based products that can provide genuine help and effective relief to millions of people suffering from a variety of qualifying conditions. Recent reports and studies indicate the approval of the Farm Bill could create a US$20 billion industry by 2022.
- Increased Patient Access With a rapidly expanding company-owned clinic network and significant expansion opportunity assuming the successful acquisition of the Sun Valley franchise model, Empower anticipates it will grow its total patient list substantially in the years ahead. This is expected to provide greater opportunity for treatment analysis using artificial intelligence (AI).
- Market Leading Technology Empower utilizes a market-leading patient electronic management and POS system that is HIPAA compliant and provides insight to patient care. The Company supports remote patients using its tele-medicine portal, enabling patients who are unable to come to a location to benefit from a doctor consultation.
> The Debentures are convertible, at the option of the Company or the holder, into units of the Company (each, a "Debenture Unit") at a conversion price of $0.11 per Debenture Unit, with each Debenture Unit consisting of one common share in the capital of the Company (each, a "Share") and one share purchase warrant (each, a "Warrant"), with each Warrant exercisable into one Share (each, a "Warrant Share") at a price of $0.16 per Warrant Share for a period of two years following the Closing, provided that the Company will have the right to accelerate the expiry date of the Warrants in the event that the closing sale price of the Shares on the Canadian Securities Exchange (the "CSE") (or such other stock exchange as the Shares are then principally traded) is greater than $0.40 per Share for a period of 10 consecutive trading days at any time after the issuance of the Warrants.
Each Unit is comprised of one Share and one Warrant, with each Warrant exercisable into one Warrant Share at an exercise price of $0.16 per Warrant Share for a period of two years following the Closing, provided that the Company will have the right to accelerate the expiry date of the Warrants in the event that the closing sale price of the Shares on the CSE (or such other stock exchange as the Shares are then principally traded) is greater than $0.40 per Share for a period of 10 consecutive trading days at any time after the issuance of the Warrants.
> The Debentures and the Units, and the underlying Shares, Warrants and Warrant Shares (collectively, the "Securities"), are subject to restrictions on resale under applicable Canadian securities laws for a period of four months and one day from the closing of the Offerings.
> None of the Securities have been or will be registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.
> This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities, in any jurisdiction in which such offer, solicitation or sale would require registration or otherwise be unlawful.
_________________________________________________________________________________
ABOUT EMPOWER
Empower is a leading owner/operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative uses of medical cannabis. It is expected that Empower's proprietary product line "Sollievo" will offer patients a variety of delivery methods of doctor recommended cannabidiol (CBD) based product options in its clinics, online and at major retailers. With over 120,000 patients, an expanding clinic footprint, a focus on new technologies, including tele-medicine, and an expanded product development strategy, Empower is undertaking new growth initiatives to be positioned as a vertically integrated, diverse, market-leading service provider for complex patient requirements in 2019 and beyond.
ABOUT AGRAFLORA
AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry. For more information please visit: www.agraflora.com
_________________________________________________________________________________
SEE > DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
https://www.newswire.ca/news-releases
_________________________________________________________________________________
Related Links
www.adiraenergy.com